Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Vos

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Journal of Cardiovascular Electrophysiology|September 28, 2001
Preclinical evaluation of antiarrhythmic drugs: new drugs should be safe to be successfulM A Vos
British Journal of Pharmacology|July 8, 2008
Literature-based evaluation of four 'hard endpoint' models for assessing drug-induced torsades de pointes liabilityM A Vos
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology|July 19, 2002
Myocardial repolarization and drugs. Impossibility to predict the dominance of anti-arrhythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodelingM A Vos, H J Crijns
Cardiovascular Research|May 30, 2001
Transmural repolarization gradients in vivo: the flukes and falls of the endocardiumM A Vos, J G Jungschleger
Journal of Cardiovascular Electrophysiology|September 2, 2000
Hybrid action potential etiologyJ G Jungschleger, M A Vos
European Heart Journal|December 1, 1992
Aviation and antiarrhythmic medicationA P Gorgels, H J Wellens, M A Vos
Circulation|January 1, 1991
Premature escape beats in vitro and in vivoA P Gorgels, M A Vos, H J Wellens
Acta Physiologica Hungarica|January 1, 1993
Effects of magnesium and ethmozin on ventricular tachycardia induced by ouabain and ventricular pacing in conscious dogs with complete atrioventricular blockT Fazekas, M A Vos, J D Leunissen, et al.
Circulation|January 1, 1990
Flunarizine allows differentiation between mechanisms of arrhythmias in the intact heartM A Vos, A P Gorgels, J D Leunissen, et al.
British Journal of Pharmacology|December 7, 2007
Drugs and trafficking of ion channels: a new pro-arrhythmic threat on the horizon?M A G van der Heyden, M E Smits, M A Vos
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Journal of Cardiovascular Electrophysiology|September 28, 2001
Preclinical evaluation of antiarrhythmic drugs: new drugs should be safe to be successfulM A Vos
British Journal of Pharmacology|July 8, 2008
Literature-based evaluation of four 'hard endpoint' models for assessing drug-induced torsades de pointes liabilityM A Vos
Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology|July 19, 2002
Myocardial repolarization and drugs. Impossibility to predict the dominance of anti-arrhythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodelingM A Vos, H J Crijns
Cardiovascular Research|May 30, 2001
Transmural repolarization gradients in vivo: the flukes and falls of the endocardiumM A Vos, J G Jungschleger
Journal of Cardiovascular Electrophysiology|September 2, 2000
Hybrid action potential etiologyJ G Jungschleger, M A Vos
European Heart Journal|December 1, 1992
Aviation and antiarrhythmic medicationA P Gorgels, H J Wellens, M A Vos
Circulation|January 1, 1991
Premature escape beats in vitro and in vivoA P Gorgels, M A Vos, H J Wellens
Acta Physiologica Hungarica|January 1, 1993
Effects of magnesium and ethmozin on ventricular tachycardia induced by ouabain and ventricular pacing in conscious dogs with complete atrioventricular blockT Fazekas, M A Vos, J D Leunissen, et al.
Circulation|January 1, 1990
Flunarizine allows differentiation between mechanisms of arrhythmias in the intact heartM A Vos, A P Gorgels, J D Leunissen, et al.
British Journal of Pharmacology|December 7, 2007
Drugs and trafficking of ion channels: a new pro-arrhythmic threat on the horizon?M A G van der Heyden, M E Smits, M A Vos
Pageof 8